financetom
Business
financetom
/
Business
/
National Vision to Repurchase $218 Million Convertible Notes; Amends Credit Agreement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Vision to Repurchase $218 Million Convertible Notes; Amends Credit Agreement
Aug 8, 2024 9:39 AM

12:05 PM EDT, 08/08/2024 (MT Newswires) -- National Vision Holdings ( EYE ) said Thursday it agreed to repurchase $218 million principal amount of 2.5% convertible notes due 2025.

The aggregate cash repurchase price for the notes is about $215 million plus accrued and unpaid interest on the notes, according to the company.

National Vision ( EYE ) also said it secured commitments to amend its existing credit agreement for $115 million of incremental term loan at the same terms as the existing loan.

The commitments are expected to close and be funded on Friday, while the repurchase transaction will close on or about Monday, the company added.

The company said after the completion of the repurchase deal remaining outstanding principal amount of 2025 notes will be about $85 million.

Price: 11.00, Change: +0.06, Percent Change: +0.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MCF Energy Provides Update on Welchau-1 Testing; Says Well Recovers Gas At Surface During Unloading Operations
MCF Energy Provides Update on Welchau-1 Testing; Says Well Recovers Gas At Surface During Unloading Operations
Mar 11, 2026
08:39 AM EST, 02/17/2026 (MT Newswires) -- MCF Energy ( MCFNF ) on Monday reported initial results from the resumption of testing of the Reifling Formation at the Welchau-1 well in Austria. In a statement the company noted that the 128-meter thick Reifling Formation is the shallowest of four carbonate reservoirs intersected at Welchau-1. It added that the well was...
Ingram Micro Wins Two Patents in the US for B2B Xvantage Platform
Ingram Micro Wins Two Patents in the US for B2B Xvantage Platform
Mar 11, 2026
07:14 AM EDT, 03/11/2026 (MT Newswires) -- Ingram Micro ( INGM ) said Wednesday that it has been awarded two US patents for proprietary technologies built into its Xvantage business-to-business platform. The first patent covers dynamic stock-keeping unit technology that automatically updates product identifiers with real-time inventory and pricing to bypass traditional catalog size limitations, the company said. The second...
OppFi Q4 Adjusted Earnings, Revenue Rise; Full-Year 2026 Guidance Issued
OppFi Q4 Adjusted Earnings, Revenue Rise; Full-Year 2026 Guidance Issued
Mar 11, 2026
07:14 AM EDT, 03/11/2026 (MT Newswires) -- OppFi ( OPFI ) reported Q4 adjusted earnings Wednesday of $0.30 per share, up from $0.23 a year earlier. Four analysts polled by FactSet expected $0.28. Revenue for the quarter ended Dec. 31 was $159.3 million, up from $135.7 million a year earlier. Four analysts expected revenue of $159.8 million. The company said...
Johnson & Johnson Says FDA Approved Monthly Dosing of Rybrevant Faspro for EGFR-Mutated Lung Cancer
Johnson & Johnson Says FDA Approved Monthly Dosing of Rybrevant Faspro for EGFR-Mutated Lung Cancer
Mar 11, 2026
08:38 AM EST, 02/17/2026 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Tuesday that the US Food and Drug Administration has approved a simplified once-monthly dosing schedule for Rybrevant Faspro in combination with Lazcluze for first-line treatment of EGFR-mutated advanced non-small cell lung cancer. The new schedule provides outcomes consistent with the previously approved bi-weekly subcutaneous regimen, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved